These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14674920)

  • 1. Homozygous familial hypercholesterolaemia: development of xanthogranuloma in a boy at puberty under long-term low-density lipoprotein apheresis and drug therapy.
    Saito M; Tada Y; Harada-Shiba M; Yamamoto A; Kusakabe N; Yokogawa M; Kodama H; Asada H; Miyagawa S
    Br J Dermatol; 2003 Dec; 149(6):1302-3. PubMed ID: 14674920
    [No Abstract]   [Full Text] [Related]  

  • 2. Homozygous familial hypercholesterolaemia.
    Macchiaiolo M; Gagliardi MG; Toscano A; Guccione P; Bartuli A
    Lancet; 2012 Apr; 379(9823):1330. PubMed ID: 22285056
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-density-lipoprotein apheresis.
    Richter WO; Schwandt P
    Lancet; 1995 Jul; 346(8967):116-7. PubMed ID: 7677855
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-density-lipoprotein apheresis.
    Olbricht CJ
    Lancet; 1995 Jul; 346(8967):116; author reply 117. PubMed ID: 7603187
    [No Abstract]   [Full Text] [Related]  

  • 5. Two Patients with Familial Hypercholesterolemia Who Were Successfully Weaned from Low-density Lipoprotein Apheresis after Treatment with Evolocumab.
    Tanaka A; Inaguma D; Watanabe Y; Ito E; Kamegai N; Shimogushi H; Shinjo H; Koike K; Otsuka Y; Takeda A
    Intern Med; 2017; 56(12):1531-1535. PubMed ID: 28626179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
    Thompson GR; Maher VM; Matthews S; Kitano Y; Neuwirth C; Shortt MB; Davies G; Rees A; Mir A; Prescott RJ
    Lancet; 1995 Apr; 345(8953):811-6. PubMed ID: 7898227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hypercholesterolemia: current treatment options and patient selection for low-density lipoprotein apheresis.
    Hemphill LC
    J Clin Lipidol; 2010; 4(5):346-9. PubMed ID: 21122676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
    Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
    Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe hypercholesterolemia by LDL-apheresis: cholesterol-lowering effect and clinical evaluation.
    Saito Y; Shinomiya M; Shirai K; Yoshida S
    Beitr Infusionsther; 1988; 23():160-71. PubMed ID: 2484772
    [No Abstract]   [Full Text] [Related]  

  • 10. Homozygous familial hypercholesterolaemia: metabolic studies and treatment with LDL apheresis.
    Mol MJ; Stalenhoef AF
    Neth J Med; 1990 Jun; 36(5-6):279-87. PubMed ID: 2395495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of familial hypercholesterolemia; secession from LDL-apheresis by the drug treatment with potent statin and resin.
    Shiina Y; Homma Y; Oguma T; Fusegawa Y; Ozawa H; Handa S; Tanabe T
    Tokai J Exp Clin Med; 2005 Sep; 30(3):149-55. PubMed ID: 16285605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Hypercholesterolaemia Regression Study and its implications.
    Watts GF
    Lancet; 1995 Apr; 345(8953):807-8. PubMed ID: 7898224
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of LDL apheresis on blood rheology in two patients with homozygous familial hypercholesterolaemia.
    Fadul JE; Sandhagen B; Linde T; Vessby B; Wikström B; Danielson BG
    Blood Purif; 1997; 15(3):182-7. PubMed ID: 9262844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous familial hypercholesterolaemia: update on management.
    France M
    Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study.
    Raal FJ; Hovingh GK; Blom D; Santos RD; Harada-Shiba M; Bruckert E; Couture P; Soran H; Watts GF; Kurtz C; Honarpour N; Tang L; Kasichayanula S; Wasserman SM; Stein EA
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):280-290. PubMed ID: 28215937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous familial hypercholesterolaemia and treatment by LDL apheresis.
    King RI; Scott RS; Florkowski CM; Laurie AD; Reid N; George PM
    N Z Med J; 2010 Jul; 123(1319):79-82. PubMed ID: 20717180
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia.
    Mabuchi H; Higashikata T; Kawashiri MA
    Transfus Apher Sci; 2004 Jun; 30(3):233-43. PubMed ID: 15172629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
    Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
    Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.
    Lepage S; Nigon F; Bonnefont-Rousselot D; Assogba U; Goulinet S; Chancharme L; Delattre J; Bruckert E; Chapman MJ
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):87-103. PubMed ID: 11150388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of LDL-apheresis on the pharmacokinetics of the lipophilic antilipidemic agent probucol.
    Komura T; Takahara K; Sugano M; Fujinishi A; Tasaki H; Nakashima Y; Kuroiwa A
    Eur J Drug Metab Pharmacokinet; 1997; 22(3):201-6. PubMed ID: 9358199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.